SCHEMBL18627896

SCHEMBL18627896

CC(C)C1C(=O)NCCN1c1ncc(-c2cccc(Nc3nccc(C4CC4)n3)c2)o1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 6/20 0.43
▸ CDK9 P50750 6/20 0.36
▸ CDK2 P24941 3/20 0.36
▸ CCNT1 O60563 2/20 0.36
▸ CCNA2 P20248 2/20 0.36
▸ CDK1 P06493 2/20 0.35
▸ CCNB1 P14635 1/20 0.35
▸ CDK7 P50613 1/20 0.35
▸ CCNH P51946 1/20 0.35
▸ CCNA1 P78396 1/20 0.35
▸ SMG1 Q96Q15 1/20 0.35
▸ BRD4 O60885 2/20 0.35
▸ FLT3 P36888 1/20 0.35
▸ ABL1 P00519 2/20 0.34
▸ BCR P11274 2/20 0.34
▸ PDGFRB P09619 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ PDGFRA P16234 1/20 0.34
▸ WEE1 P30291 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18627910 0.90 SYK (0.47) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627951 0.90 SYK (0.47) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627905 0.90 SYK (0.45) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627908 0.90 SYK (0.47) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627918 0.89 SYK (0.45) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627919 0.88 SYK (0.43) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627930 0.88 SYK (0.43) SYKCDK9CDK2CCNT1CCNA2
SCHEMBL18627899 0.87 SYK (0.46) SYK
SCHEMBL18627912 0.86 SMG1 (0.44) SYKCDK9CDK2CCNT1CDK1
SCHEMBL18627959 0.85 SYK (0.42) SYKCDK9CDK2CCNT1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3350176-B1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2021-04-28 — — EP claimed
US-10392373-B2 Oxazole derivatives that inhibit Syk AB SCIENCE (FR) 2019-08-27 — — US claimed
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2019-02-21 — — US claimed
EP-3144307-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2017-03-22 — — EP claimed
EP-3350176-B1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2021-04-28 — — EP disclosed
US-10392373-B2 Oxazole derivatives that inhibit Syk AB SCIENCE (FR) 2019-08-27 — — US disclosed
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2019-02-21 — — US disclosed
EP-3350176-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2018-07-25 — — EP disclosed
WO-2017046302-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB SCIENCE (FR) 2017-03-23 — — WO disclosed
EP-3144307-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2017-03-22 — — EP disclosed
EP-3144307-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK AB Science (FR) 2017-03-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190055230-A1 NOVEL OXAZOLE DERIVATIVES THAT INHIBIT SYK SYK, BTK, LCK SYK 1/4885CDK9 681/4885CDK2 841/4885
US-10392373-B2 Oxazole derivatives that inhibit Syk SYK, BTK, LCK SYK 1/4885CDK9 604/4885CDK2 821/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback